Story · Medicine & Biotech

Mounjaro tops Ozempic in real-world diabetes data

2 outlets · first reported by Longevity.Technology 16d ago · latest 15d ago · 32 hours of coverage · 2 countries

Coverage, in order

  1. 16d ago
    first Longevity.Technology UK indie
    Mounjaro tops Ozempic in real-world diabetes data

    GlobalData says more adults with type 2 diabetes in England hit blood sugar and weight targets on tirzepatide than on semaglutide. About one in four. That’s how many people with type 2 diabetes (T2D) on tirzepatide had lost at least 15% of their body weight a year after starting, according to…

  2. 15d ago
    Healthline mainstream study observational
    Increasing Ozempic Dose Linked to Lower Heart Risk Than Switching to Mounjaro

    Recent research suggests that increasing your Ozempic dose may offer greater heart protection than switching to Mounjaro. Eva Kongshavn · Moment/Getty A real-world study found that people with type 2 diabetes who increased their Ozempic dose rather than switching to Mounjaro had a lower risk of…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.